These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2312770)

  • 21. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 22. Gallamine and pancuronium inhibit pre- and postjunctional muscarine receptors in canine saphenous veins.
    Vercruysse P; Bossuyt P; Hanegreefs G; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1979 May; 209(2):225-30. PubMed ID: 438998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and use of muscle relaxants in infants and children.
    Nugent SK; Laravuso R; Rogers MC
    J Pediatr; 1979 Mar; 94(3):481-7. PubMed ID: 423041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of equipotent doses of non-depolarizing muscle relaxants in children.
    Goudsouzian NG; Liu LM; Coté CJ
    Anesth Analg; 1981 Dec; 60(12):862-6. PubMed ID: 6274233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-lasting neuromuscular effects of non-depolarizing muscle relaxants, as measured by tetanic stimulation (author's transl)].
    Barth L; Dannhorn R
    Anaesthesist; 1977 Mar; 26(3):116-24. PubMed ID: 857690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative potency of some neuromuscular blocking drugs in vivo and in vitro.
    Anttila P; Ertama P
    Med Biol; 1978 Jun; 56(3):152-5. PubMed ID: 682698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.
    Nedoma J; Dorofeeva NA; Tucek S; Shelkovnikov SA; Danilov AF
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):176-81. PubMed ID: 4010794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated onset and delayed recovery of d-tubocurarine blockade with pancuronium in infants and children.
    Smith CE; Baxter M; Bevan JC; Donati F; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):555-9. PubMed ID: 3677278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modes of acton of muscle relaxants].
    Yoshino M
    Masui; 1972 Apr; 21(4):321-35. PubMed ID: 4261711
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of pretreatment with nondepolarizing muscle relaxants on the neuromuscular blocking action of succinylcholine.
    Cullen DJ
    Anesthesiology; 1971 Dec; 35(6):572-8. PubMed ID: 4256556
    [No Abstract]   [Full Text] [Related]  

  • 31. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of prior administration of a non-depolarising muscle relaxant on the action of suxamethonium in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 May; 36(3):348-53. PubMed ID: 6463378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency and onset of action of neuromuscular blocking drugs.
    Wierda JM; van den Broek L; Schiere S; Maestrone E
    Anesth Analg; 1995 Jun; 80(6):1249-50. PubMed ID: 7762863
    [No Abstract]   [Full Text] [Related]  

  • 34. Ketamine and muscle relaxants.
    Wilson A
    Br J Anaesth; 1973 Jan; 45(1):115-6. PubMed ID: 4266737
    [No Abstract]   [Full Text] [Related]  

  • 35. Some aspects of ocular function after precurarization.
    Eriksen S; Bramsen T; Hommelgaard P
    Acta Anaesthesiol Scand; 1977; 21(5):385-9. PubMed ID: 143866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium.
    Gyermek L; Cantley EM
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):600-5. PubMed ID: 7874374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of precurarization to suxamethonium to provide ease of intubation and to prevent post-suxamethonium muscle pains.
    Wig J; Bali IM
    Can Anaesth Soc J; 1979 Mar; 26(2):94-8. PubMed ID: 466557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of muscle relaxants.
    Katz LE
    AANA J; 1981 Feb; 49(1):35-42. PubMed ID: 7234311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.